We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AnaSpec Now Offers Custom Synthesis of Stapled Helical Peptides
Product News

AnaSpec Now Offers Custom Synthesis of Stapled Helical Peptides

AnaSpec Now Offers Custom Synthesis of Stapled Helical Peptides
Product News

AnaSpec Now Offers Custom Synthesis of Stapled Helical Peptides


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "AnaSpec Now Offers Custom Synthesis of Stapled Helical Peptides"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Unnatural amino acid (S5 and R8) substitutions flank three (substitution positions i and i + 4 using S5 and S5, e.g. XXXXX-S5-XXX-S5-XXXXX) or six standard amino acids (i and i + 7 using R8 and S5, e.g. XXXXXX-R8-XXXXXX-S5-XXXXX).



Many biological pathways, such as signal transduction, occur because of intracellular protein-protein interactions, which frequently are mediated by the a-helix structures of proteins; however, the use of short protein fragments (peptides) generally leads to the loss of secondary structure, such as alpha helical structure.



Short peptides also are easily degraded by proteolysis and have difficulty in intact cells penetration.1 Verdine’s group has shown that these problems could be overcome by a chemical modification of an alpha-helical peptide they termed hydrocarbon-stapled peptide.1,2 The modified hydrocarbon-stapled peptide was helical and relatively protease resistant. The modification resulted in cell-permeable peptides that bind with increased binding affinity for its target, and may provide a useful strategy for experimental and therapeutic modulation of protein-protein interactions in many signaling pathways related to apoptosis in cancer cells as well as in vivo pharmacokinetics and efficacy in disease models.



References:


    1.     Walensky, LD. et al. Science 305, 1466 (2004).

    2.     Schafmeister, CE. et al. J. Am. Chem. Soc. 122, 5891 (2002).

Advertisement